Keywords: Breast, biomarkers, neoadjuvant chemotherapy
Motivation: The motivation is early assessment of pathologic complete response (pCR) after neoadjuvant chemotherapy in breast cancer.
Goal(s): To evaluate whether the change in multiparametric MRI could help early predict the response to NAC.
Approach: We analyzed the percentage change in wash-in slope (WIS), tumor ADC, and tumor size from that before treatment at each time point of 221 breast cancer cases, utilizing Student's t-test and the receiver operating characteristic curve.
Results: The change in WIS demonstrated strong predictive performance for pCR, whereas the models incorporating the change of WIS, ADC, and size exhibited comparable predictive performance between each time point.
Impact: This study is highly impactful, as it demonstrates that MRI biomarkers can dynamically predict the response to NAC, with the combination of kinetic and diffusion parameters enabling early prediction of treatment response.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords